These findings were also confirmed using tumor tissue section and staining analysis (Figure S40-S42), which demonstrated that Nano-IFNγ/Zole could inhibit local recurrence of colorectal cancer after iRFA treatment by remodeling the suppressive TIME. The gene discussed is IFNG; the disease is colorectal cancer.